Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Receivables (2016 - 2026)

Integra Lifesciences Holdings' Receivables history spans 17 years, with the latest figure at $285.7 million for Q4 2025.

  • On a quarterly basis, Receivables rose 2.58% to $285.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $285.7 million, a 2.58% increase, with the full-year FY2025 number at $285.7 million, up 2.58% from a year prior.
  • Receivables hit $285.7 million in Q4 2025 for Integra Lifesciences Holdings, up from $267.1 million in the prior quarter.
  • Over the last five years, Receivables for IART hit a ceiling of $288.0 million in Q2 2025 and a floor of $230.0 million in Q1 2021.
  • Historically, Receivables has averaged $259.5 million across 5 years, with a median of $260.8 million in 2023.
  • The widest YoY moves for Receivables: up 27.46% in 2021, down 9.25% in 2021.
  • Tracing IART's Receivables over 5 years: stood at $243.2 million in 2021, then grew by 12.47% to $273.6 million in 2022, then decreased by 1.84% to $268.6 million in 2023, then rose by 3.71% to $278.5 million in 2024, then grew by 2.58% to $285.7 million in 2025.
  • Business Quant data shows Receivables for IART at $285.7 million in Q4 2025, $267.1 million in Q3 2025, and $288.0 million in Q2 2025.